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Clinics 
Age and sex 
75 years old female patient. 
Previous history 
No preleukemia. No previous malignancy. No inborn 
condition of note. 
Organomegaly 
No hepatomegaly, no splenomegaly, no enlarged lymph 
nodes, no central nervous system involvement. 
Blood 
WBC: 3.00 X 109/l 
HB: 9.0g/dl 
Platelets: 37.000 X 109/l 
Blasts: 18%% 
Bone marrow: 90%. Hypercellular (90%) bone 
marrow with at least 30% blasts. There was dysplasia 






Flow cytometry identified a population of blasts of 
myeloid origin encompassing 31% of cells. The blasts 
were expressing CD13, CD33, CD34, CD117, HLA-
DR, and CD56. 
Rearranged Ig Tcr 
Not performed. 
Pathology 
Increased and poorly maturing myeloid leukogenesis. 
Increased erythrocytogenesis with dysplastic forms 
(nuclear budding and megaloblastoid changes). 
Megakaryocytogenesis was markedly increased with 





Acute myeloid leukemia with multilineage dysplasia. 
Survival 
Date of diagnosis: 09-2009 
Treatment: Gemtuzumab Ozogamicin, and 5-
Azacitidine. 
Complete remission: None 
Status: Dead 
Last follow up: 11-2009 
Survival: 2 months 
Karyotype 
Sample: Bone marrow aspirate. 
Culture time: 24h without stimulating agents and 48hr 
with 10% conditioned medium. 
Banding: GTG. 
Results: Analysis of 20 metaphase cells revealed an 
abnormal female karyotype in all metaphases. Very 
complex chromosomal abnormalities were  
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G-banded karyotype showing 45,X,add(X)(q22),-3,del(5)(q13q33), hsr(11)(q23),add(12)(p11.2),-17,+r[cp20]. 
 
identified. karyotype was designated; 
45,X,add(X)(q22),-3,del(5)(q13q33),hsr(11)(q23), 
add(12)(p11.2),-17,+r[cp20]. 
Other Molecular Studies 
Technics: 
Fluorescence in situ hybridization (FISH) using the LSI 
EGR1/(5q31)/ D5S23:D5S721 dual color, LSI 
MLL/11q23 dual color breakapart DNA probes, and 
whole chromosome paint (WCP) 11 was performed 
(Vysis Inc. Downers Grove, IL). 
Results: 
Deletion of EGR1/5q31 was seen in 25% of cells and 
amplification of MLL/11q23 gene was found in 60% of 
cells. MLL signals appeared fused indicating lack of 
MLL rearrangement.  
FISH with LSI MLL/11q23 probe showing amplification of MLL 
gene (arrow) along with one normal copy. 
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WCP 11 spectrum green on the same metaphase in figure 2 
showing two painting signals indicating that the amplified MLL 
located on chromosome 11 (arrow). 
Comments 
The case described here is of a 75-year-old female who 
was diagnosed with AML with multilineage dysplasia. 
Cytogenetics revealed a complex aberrant karyotype 
(CAK) including deletion of 5q and loss of 
chromosome 17. In addition, FISH confirmed deletion 
of EGR1/5q31 and showed amplification of 
MLL/11q23 gene in the form of hsr at 11q. Literature 
suggests an association of amplification of MLL with 
CAK. Moreover, deletions of 5/5q and 17/17p, such as 
in our case, are frequently found along with MLL 
amplification. Previously reported AML cases with 
MLL amplifications tend to occur in elderly patients, 
and are characterized by rapid progression, poor 
response to treatment, and poor clinical outcome. The 
present case supports the notion that MLL 
amplification is commonly found in the setting of CAK 
with deletion of chromosome 5 and 17. Thus, the 
presence of MLL amplification along with deletion 5q 
in AML cases appears to be a genomic pattern which 
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